Terms: = Breast cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C
20 results:
1. Functional delineation of the luminal epithelial microenvironment in breast using cell-based screening in combinatorial microenvironments.
Jokela TA; Dane MA; Smith RL; Devlin KL; Shalabi S; Lopez JC; Miyano M; Stampfer MR; Korkola JE; Gray JW; Heiser LM; LaBarge MA
Cell Signal; 2024 Jan; 113():110958. PubMed ID: 37935340
[TBL] [Abstract] [Full Text] [Related]
2. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer.
Rodríguez Pérez A; Felip Font E; Chicas-Sett R; Montero-Luis Á; de Paz Arias L; González-Del-Alba A; López-Campos F; López López C; Hernando Requejo O; Conde-Moreno AJ; Arranz Arija JÁ; de Castro Carpeño J
Clin Transl Oncol; 2023 Apr; 25(4):882-896. PubMed ID: 36525231
[TBL] [Abstract] [Full Text] [Related]
3. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
Conde-Moreno AJ; González-Del-Alba A; López-Campos F; López López C; Requejo OH; de Castro Carpeño J; Chicas-Sett R; de Paz Arias L; Montero-Luis Á; Pérez AR; Font EF; Arija JÁA
Clin Transl Oncol; 2023 Apr; 25(4):897-911. PubMed ID: 36525230
[TBL] [Abstract] [Full Text] [Related]
4. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study.
Kroese TE; Takahashi Y; Lordick F; van Rossum PSN; Ruurda JP; Lagarde SM; van Hillegersberg R; Verhoeven RHA; van Laarhoven HWM
Eur J Cancer; 2023 Jan; 179():65-75. PubMed ID: 36509000
[TBL] [Abstract] [Full Text] [Related]
5. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Inoue Y; Fujishima M; Ono M; Masuda J; Ozaki Y; Maeda T; Uehiro N; Takahashi Y; Kobayashi T; Sakai T; Osako T; Ueno T; Ohno S
Breast Cancer Res Treat; 2022 Nov; 196(2):341-348. PubMed ID: 36153381
[TBL] [Abstract] [Full Text] [Related]
7. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
[TBL] [Abstract] [Full Text] [Related]
8. Patient and Treatment Factors Associated With Improved Local Control and Survival in Oligometastatic Bone Disease: Results From a Large Single-Institution Experience Using Stereotactic Body Radiation Therapy.
Thomas MC; Chen YH; Fite E; Pangilinan A; Bubelo K; Spektor A; Balboni TA; Huynh MA
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):747-761. PubMed ID: 35840113
[TBL] [Abstract] [Full Text] [Related]
9. Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
Piroth MD; Krug D; Feyer P; Baumann R; Combs S; Duma MN; Dunst J; Fastner G; Fietkau R; Guckenberger M; Haase W; Harms W; Hehr T; Sedlmayer F; Souchon R; Strnad V; Budach W
Strahlenther Onkol; 2022 Jul; 198(7):601-611. PubMed ID: 35527272
[TBL] [Abstract] [Full Text] [Related]
10. The continuing conundrum in oligometastatic breast carcinoma: A real-world data.
Selvarajan G; Dhanushkodi M; Radhakrishnan V; Kalaiyarasi JP; Murali CS; Ananthi B; Iyer P; Krishnamurthy A; Velusamy S; Ganesarajah S; Sagar TG
Breast; 2022 Jun; 63():140-148. PubMed ID: 35395472
[TBL] [Abstract] [Full Text] [Related]
11. Approach to Oligometastatic cancer in the Elderly Patient.
Winter IW; Smile TD; Videtic GMM
Curr Oncol Rep; 2021 Aug; 23(11):122. PubMed ID: 34448967
[TBL] [Abstract] [Full Text] [Related]
12. Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
Chen X; Chen H; Poon I; Erler D; Badellino S; Biswas T; Dagan R; Foote M; Louie AV; Ricardi U; Sahgal A; Redmond KJ
Cancer Med; 2021 Sep; 10(18):6189-6198. PubMed ID: 34432390
[TBL] [Abstract] [Full Text] [Related]
13. [Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa].
Kajimina Katumbayi JC; Muyulu NP; Zakayi PK; Lebwaze Massamba B; Sitwaminya RK; Beya Kabongo F; Kisile Mikuwo O; Baleka AM; Kabongo Mpolesha JM; Nicaise M; Chirimwami RB
Gynecol Obstet Fertil Senol; 2022 Jan; 50(1):53-61. PubMed ID: 34242824
[TBL] [Abstract] [Full Text] [Related]
14. Imaging and its Impact on Defining the Oligometastatic State.
Pirasteh A; Lovrec P; Pedrosa I
Semin Radiat Oncol; 2021 Jul; 31(3):186-199. PubMed ID: 34090645
[TBL] [Abstract] [Full Text] [Related]
15. Integrating Microstructured Electrospun Scaffolds in an Open Microfluidic System for
Guida P; Piscitelli E; Marrese M; Martino V; Cirillo V; Guarino V; Angeli E; Cocola C; Pelucchi P; Repetto L; Firpo G; Karnavas T; Gotte M; Gritzapis A; D'Albore M; Repetto D; Pezzuoli D; Missitzis I; Porta G; Bertalot G; Bellipanni G; Zucchi I; Ambrosio L; Valbusa U; Reinbold RA
ACS Biomater Sci Eng; 2020 Jun; 6(6):3649-3663. PubMed ID: 33463182
[TBL] [Abstract] [Full Text] [Related]
16. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of cancer imaging group.
deSouza NM; Liu Y; Chiti A; Oprea-Lager D; Gebhart G; Van Beers BE; Herrmann K; Lecouvet FE
Eur J Cancer; 2018 Mar; 91():153-163. PubMed ID: 29331524
[TBL] [Abstract] [Full Text] [Related]
17. Management of liver dominant metastatic breast cancer: surgery, chemotherapy, or hepatic arterial therapy - benefits and limitations.
Rodes Brown S; Martin RC
Minerva Chir; 2012 Aug; 67(4):297-308. PubMed ID: 23022754
[TBL] [Abstract] [Full Text] [Related]
18. Age pattern of the occurrence of breast cancer in the northwest of Iran.
Eivazi-Ziaei J; Dastgiri S; Kermani IA; Nikanfar A; Esfahani A; Sanaat Z; Sadeghi-Bazargani H; Vaez J
Indian J Cancer; 2011; 48(4):406-9. PubMed ID: 22293252
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy.
Chan A; Chen C; Chiang J; Tan SH; Ng R
Support Care Cancer; 2012 Jul; 20(7):1525-32. PubMed ID: 21818641
[TBL] [Abstract] [Full Text] [Related]
20. Common malignancy-associated regions of transcriptional activation (MARTA) in human prostate, breast, ovarian, and colon cancers are targets for DNA amplification.
Glinsky GV; Ivanova YA; Glinskii AB
Cancer Lett; 2003 Nov; 201(1):67-77. PubMed ID: 14580688
[TBL] [Abstract] [Full Text] [Related]
